These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7513514)

  • 41. Tyrphostin inhibits bombesin stimulation of tyrosine phosphorylation, c-fos expression, and DNA synthesis in Swiss 3T3 cells.
    Seckl M; Rozengurt E
    J Biol Chem; 1993 May; 268(13):9548-54. PubMed ID: 7683655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of tyrosine kinase activity has multiple actions on insulin release from the pancreatic beta-cell: studies with lavendustin A.
    Hisatomi M; Hayakawa T; Hidaka H; Niki I
    Jpn J Pharmacol; 1997 Jun; 74(2):203-8. PubMed ID: 9243329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway. Evidence for UVB-induced epidermal growth factor receptor activation.
    Miller CC; Hale P; Pentland AP
    J Biol Chem; 1994 Feb; 269(5):3529-33. PubMed ID: 8106395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of cyclic AMP levels in a clonal neural cell line by inhibitors of tyrosine phosphorylation.
    Stringfield TM; Morimoto BH
    Biochem Pharmacol; 1997 May; 53(9):1271-8. PubMed ID: 9214688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potent activation of phospholipase D by phenylarsine oxide in rat basophilic leukemia (RBL-2H3) cells.
    Kumada T; Nakashima S; Miyata H; Nozawa Y
    Biochem Biophys Res Commun; 1994 Mar; 199(2):792-8. PubMed ID: 8135825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tyrosine phosphorylation is required for ehrlichial internalization and replication in P388D1 cells.
    Zhang Y; Rikihisa Y
    Infect Immun; 1997 Jul; 65(7):2959-64. PubMed ID: 9199472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of tyrosine phosphorylation potentiates substrate-induced neurite growth.
    Bixby JL; Jhabvala P
    J Neurobiol; 1992 Jul; 23(5):468-80. PubMed ID: 1279111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of bradykinin- and thapsigargin-induced Ca2+ entry by tyrosine kinase inhibitors.
    Lee KM; Toscas K; Villereal ML
    J Biol Chem; 1993 May; 268(14):9945-8. PubMed ID: 7683685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor.
    Zhao M; Kiyoi H; Yamamoto Y; Ito M; Towatari M; Omura S; Kitamura T; Ueda R; Saito H; Naoe T
    Leukemia; 2000 Mar; 14(3):374-8. PubMed ID: 10720129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.
    Tallett A; Chilvers ER; Hannah S; Dransfield I; Lawson MF; Haslett C; Sethi T
    Cancer Res; 1996 Sep; 56(18):4255-63. PubMed ID: 8797601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for direct modification of NF kappa B by the tyrosine kinase inhibitor, herbimycin A.
    Mahon TM; O'Neill LA
    Biochem Soc Trans; 1995 Feb; 23(1):111S. PubMed ID: 7538940
    [No Abstract]   [Full Text] [Related]  

  • 52. Requirement for tyrosine phosphorylation in lipopolysaccharide-induced murine B-cell proliferation.
    Dearden-Badet MT; Revillard JP
    Immunology; 1993 Dec; 80(4):658-60. PubMed ID: 8307617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Responses of smooth muscle cells to platelet-derived growth factor are inhibited by herbimycin-A tyrosine kinase inhibitor.
    Fujio Y; Yamada F; Takahashi K; Shibata N
    Biochem Biophys Res Commun; 1993 Aug; 195(1):79-83. PubMed ID: 7689842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein tyrosine kinase activation provides an early and obligatory signal in anti-FRP-1/CD98/4F2 monoclonal antibody induced cell fusion mediated by HIV gp160.
    Tabata N; Ido M; Suga S; Ohgimoto S; Tsurudome M; Kawano M; Nishio M; Watanabe N; Okamoto K; Komada H; Sakurai M; Ito Y
    Med Microbiol Immunol; 1997 Oct; 186(2-3):115-23. PubMed ID: 9403839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A.
    Uehara Y; Murakami Y; Mizuno S; Kawai S
    Virology; 1988 May; 164(1):294-8. PubMed ID: 2452516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells.
    Bagnato A; Tecce R; Di Castro V; Catt KJ
    Cancer Res; 1997 Apr; 57(7):1306-11. PubMed ID: 9102218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein.
    Zhang ZH; Wang Q
    Pflugers Arch; 2000 Sep; 440(5):784-92. PubMed ID: 11007322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surfactant protein A regulates pulmonary surfactant secretion via activation of phosphatidylinositol 3-kinase in type II alveolar cells.
    White MK; Strayer DS
    Exp Cell Res; 2000 Feb; 255(1):67-76. PubMed ID: 10666335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transforming growth factor-alpha increases tyrosine phosphorylation of microtubule-associated protein kinase in a small intestinal crypt cell line (IEC-6).
    Oliver BL; Sha'afi RI; Hajjar JJ
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):455-60. PubMed ID: 7980404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion.
    Sorenson RL; Brelje TC; Roth C
    Endocrinology; 1994 Apr; 134(4):1975-8. PubMed ID: 8137766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.